Embody vs altRx
Both are cash-pay compounding programs at the value end of the market, so this comes down to specifics. Embody leans on flat, transparent pricing ($69 semaglutide, $119 tirzepatide) and fast shipping. altRx edges it on the absolute entry structure ($89 semaglutide, $149 for the GLP-1/GIP option), adds financing, and uniquely offers brand-name Wegovy and Zepbound alongside the compounded options.
Last reviewed 2026-09-01 · Pricing is provider-reported and changes often — confirm current rates on each provider's site. We may earn a commission.
Educational, not medical advice. This page explains GLP-1 medications in general terms. Only a licensed clinician who knows your history can decide what's right for you.
Embody edges it on the lowest flat monthly price and fastest shipping — altRx is the pick only if you specifically want financing or a brand-name off-ramp.
View Plan: embodyChoose embody if…
you value flat, predictable pricing and fast 1–2 day shipping above all.
Choose altRx if…
you want financing, or the option to move to brand-name Wegovy/Zepbound later.
Cost breakdown
The numbers that actually decide it, side by side.
| | |
|---|---|---|
| Semaglutide, monthly | $69/mo flat | $89/mo |
| Tirzepatide / GLP-1+GIP, monthly | $119/mo flat | From $149/mo |
| ~6-month semaglutide total | ~$414 | ~$534 |
| Financing | — | Buy Now, Pay Later |
| Brand-name option | No | Yes — Wegovy, Zepbound |
| Shipping | Free 1–2 day | Included |
On the headline monthly numbers, Embody is a touch cheaper: $69/mo semaglutide versus altRx's $89/mo, and $119/mo tirzepatide versus altRx's $149/mo for the GLP-1/GIP option. Over six months of semaglutide that's roughly $414 (Embody) versus $534 (altRx) — a real but not enormous gap.
altRx narrows or reverses that advantage in two ways. First, it offers Buy Now, Pay Later, which matters if cash flow — not total cost — is your constraint. Second, it's one of the few programs that also sells brand-name Wegovy and Zepbound, so you're not locked into compounded if you later want (or your clinician recommends) the FDA-approved product.
Both are compounded-first, cash-pay, and both lean on the same compounding safeguards. So this is less 'which is legit' and more 'do I want the lowest flat rate (Embody) or maximum flexibility and a brand-name off-ramp (altRx)'.
Full specs, side by side
| | |
|---|---|---|
| Starting price | $69/mo (compounded semaglutide) | $89/mo (compounded semaglutide) |
| Compounded semaglutide | $69/mo flat (compounded) | $89/mo (compounded) |
| Tirzepatide | $119/mo flat (compounded) | From $149/mo (compounded GLP-1 + GIP) |
| GLP-1 + GIP option | Yes — tirzepatide is a GLP-1/GIP dual agonist, $119/mo | Yes — compounded tirzepatide (GLP-1 + GIP) from $149/mo |
| Offering type | Compounded | Both |
| New-patient offer | Flat pricing (no intro-then-hike model) | Buy Now, Pay Later financing available |
| Billing model | Monthly, flat rate | Monthly plans; multi-month options |
| What's included | Visit with licensed doctor, Medication, Free 1–2 day shipping | Online medical evaluation, Medication, Shipping, Dose adjustments |
| Lab work | Online intake | Online intake; labs may be requested for some patients |
| Shipping | Free 1–2 day shipping | Included |
| Refills | Monthly refills | Monthly refills |
| States | Most US states | Most US states |
| Pharmacy | 503A pharmacies; LegitScript-certified | US compounding pharmacies (503A); brand via licensed pharmacies |
| Clinicians | US-licensed doctors | US-licensed prescribers |
| Insurance | Cash only | Cash; Buy Now, Pay Later available |
| Consultation | Online visit with licensed doctors | Asynchronous online medical intake |
| Our rating | 9.9 · Exceptional | 9.6 · Excellent |
Medications & formulations
- Both offer compounded semaglutide and compounded tirzepatide (the GLP-1/GIP dual agonist).
- altRx additionally offers brand-name Wegovy and Zepbound — useful if you want a path to an FDA-approved finished product without switching providers.
New to the drugs themselves? Read our plain-language guides to semaglutide and tirzepatide.
Pros & cons
Pros
- Flat, published pricing with no tiers to decode
- Both semaglutide and tirzepatide offered
- Free 1–2 day shipping
- LegitScript certification and 503A pharmacies stated upfront
Cons
- Compounded only — no brand-name Wegovy/Zepbound
- Cash-pay only (no insurance billing)
Pros
- Lowest published compounded entry price in our list
- Rare option to choose compounded OR brand-name in one place
- Buy Now, Pay Later spreads the cost
- No insurance needed to start
Cons
- Compounded products aren't FDA-approved finished drugs
- Brand-name pricing depends on insurance/eligibility
Where each one has the edge
We don't tally a winner — that hides the trade-offs. Here's who leads on each dimension and why.
Embody's $69/$119 flat rate undercuts altRx's $89/$149.
altRx also offers brand Wegovy and Zepbound; Embody is compounded-only.
Embody's flat, published pricing is very easy to reason about.
altRx offers Buy Now, Pay Later.
Embody's free 1–2 day shipping is a standout.
Match by your priority
The fastest way to decide: find your top priority, see which program we'd point you to.
If your priority is You want the lowest monthly price
If your priority is You want the option to switch to brand later
If your priority is You want to spread payments out
If your priority is You want the fastest delivery
Embody vs altRx: common questions
The bottom line
Two strong value picks with the same core model. Choose Embody for the lowest flat price and fastest shipping; choose altRx if you want financing or a brand-name option in reserve. The monthly difference is modest, so let the extras decide.
How we compare — and how to read this
We compare programs on the factors that actually affect a patient: real price (including whether it's compounded or branded), medications and formulations offered, shipping, pharmacy accreditation and clinician model, insurance stance, and commitment. We name a top pick for most people, but we show the trade-offs in full so you can override it when your priorities or insurance point the other way. Pricing is provider-reported and changes frequently — and compounded-drug availability shifts with FDA shortage status — so always confirm the current details on the provider's own site before enrolling. Affiliate relationships do not change a program's placement. This page is educational and not medical advice; see our disclaimer.